JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
Cost of Revenue Over TimeStable
Percentile Rank64
3Y CAGR+19.4%
5Y CAGR+11.7%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+19.4%/yr
vs -15.1%/yr prior
5Y CAGR
+11.7%/yr
Recent acceleration
Acceleration
+34.6pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
3 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $25.36B | +7.8% |
| 2024 | $23.51B | +13.0% |
| 2023 | $20.82B | +39.9% |
| 2022 | $14.88B | -3.1% |
| 2021 | $15.36B | +5.6% |
| 2020 | $14.55B | -58.7% |
| 2019 | $35.22B | +22.8% |
| 2018 | $28.69B | +43.5% |
| 2017 | $19.99B | -5.6% |
| 2016 | $21.17B | - |